GLP-1 Receptor Agonists Added to Statin Therapy and Cardiovascular Outcomes in ASCVD A Propensity…

Cardiovascular Outcomes in Patients with Type 2 Diabetes and Heart Failure with Reduced Ejection using Glucagon-like Peptide-1 Receptor Agonists
M. Al-Nusair, A. Maini, S. Khurana +1
medRxiv21 Sep 2026PreprintCC BYFull textCardiovascular medicinemedRxiv
Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study.
Hyung-Jun Lim, Kunye Kwak, Changgon Kim +5
Research and practice in thrombosis and haemostasis29 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study
Muhammad Ali Ibrahim Kazi, Syed Musa Mufarrih, Akanksha Sirohi +5
PLOS One24 Sep 2026Peer-reviewedCC BY 4.0Full textImmunology Cardiovascular medicinePLOS
Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
Alaa Solaiman Algazzar
Saudi Journal of Internal Medicine1 Sep 2026Peer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease
Tanawan Kongmalai, Natthakan Chitpim, Varalak Srinonprasert +2
Scientific Reports6 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismCrossref

Cite

BibTeX

@misc{tah2026glp1,
  title = {{GLP-1 Receptor Agonists Added to Statin Therapy and Cardiovascular Outcomes in ASCVD A Propensity Score-Matched Cohort Study}},
  author = {S. Tah and M. Cheshire},
  howpublished = {medRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.05.26367396},
  url = {https://www.medrxiv.org/content/10.64898/2026.11.05.26367396v1},
}

RIS

TY  - UNPB
TI  - GLP-1 Receptor Agonists Added to Statin Therapy and Cardiovascular Outcomes in ASCVD A Propensity Score-Matched Cohort Study
AU  - S. Tah
AU  - M. Cheshire
PY  - 2026
DA  - 2026/11/05
PB  - medRxiv
DO  - 10.64898/2026.11.05.26367396
UR  - https://www.medrxiv.org/content/10.64898/2026.11.05.26367396v1
ER  -

Related

Cite